A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models.

Photodiagnosis Photodyn Ther

School of Computer Science and Engineering, Vellore Institute of Technology, Chennai, India. Electronic address:

Published: December 2024

Age-related Macular Degeneration (AMD) is a leading cause of visual impairment and blindness that affects the eye from the age of fifty-five and older. It impacts on the retina, the light-sensitive layer of the eye. In early AMD, yellowish deposits called drusen, form under the retina, which could result in distortion and gradual blurring of vision. The presence of drusen is the first sign of early dry AMD. As the disease progresses, more and larger deposits develop, and blood vessels grow up from beneath the retina leading to leakage of blood, that damages the retina. In advanced AMD, peripheral vision may remain, but the straight vision is lost. Detecting AMD early is crucial, but treatments are limited, and nutritional supplements like AREDS2 formula may slow disease progression. AMD diagnosis is primarily achieved through drusen identification, a process involving fundus photography by ophthalmologists, but the early stages of AMD make this task challenging due to ambiguous drusen regions. Furthermore, the existing models have difficulty in correctly predicting the drusen regions because of the resolution of fundus images, for which a solution is proposed as a model based on deep learning. Performance can be optimized by employing both local and global knowledge when AMD issues are still in the early phases. The area of the retina where drusen forms were identified by image segmentation, and then these deposits were automatically recognized through pattern recognition techniques.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2024.104454DOI Listing

Publication Analysis

Top Keywords

age-related macular
8
macular degeneration
8
deep learning
8
amd
8
drusen regions
8
drusen
7
early
6
retina
5
comprehensive review
4
review early
4

Similar Publications

Non-canonical roles of CFH in retinal pigment epithelial cells revealed by dysfunctional rare CFH variants.

Stem Cell Reports

December 2024

Department of Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. Electronic address:

Complement factor H (CFH) common genetic variants have been associated with age-related macular degeneration (AMD). While most previous in vitro RPE studies focused on the common p.His402Tyr CFH variant, we characterized rare CFH variants that are highly penetrant for AMD using induced pluripotent stem-cell-derived retinal pigment epithelium (iPSC-RPE).

View Article and Find Full Text PDF

Our objective is to determine the protein and complements constituents of Cord blood Platelet-rich plasma (CB-PRP), based on the hypothesis that it contains beneficial components capable of arresting or potentially decelerating the advancement of atrophic age-related macular degeneration (dry-AMD), with the support of radiomics. Two distinct pools of CB-PRP were assessed, each pool obtained from a total of 15 umbilical cord-blood donors. One aliquot of each pool respectively was subjected to proteomic analysis in order to enhance the significance of our findings, by identifying proteins that are shared between the two sample pools and gaining insights into the pathways they are associated with.

View Article and Find Full Text PDF

A novel quantitative angiogenesis assay based on visualized vascular organoid.

Angiogenesis

January 2025

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Clinical Stem Cell Research Center, Peking University Third Hospital, Peking University, Beijing, 100191, China.

Angiogenesis describes the sprouting of blood vessels from existing vasculatures and it plays a pivotal role in disease progress such as diabetes, age-related macular degeneration and cancer. However, the most widely used anti-angiogenic agents targeting vascular endothelial growth factor (VEGF) pathway still lacked of specificity and therapeutic efficacy. To establish a method suitable for high-throughput drug screening and faithfully recapitulate the feature of in vivo angiogenesis, we generated a PECAM1-mRuby3-secNluc; ACTA2-EGFP dual reporter human pluripotent stem cell (hPSC) line and utilizing the cell line to establish a visualized and quantifiable in vitro angiogenesis model with stem cell-derived vascular organoid.

View Article and Find Full Text PDF

Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration.

Drug Deliv Transl Res

January 2025

Pharmaceutical Research and Development, Ezequiel Dias Foundation, Rua Conde Pereira Carneiro 80, Gameleira, Belo Horizonte, CEP 30510-010, Minas Gerais, Brazil.

Current treatments for retinal disorders are anti-angiogenic agents, laser photocoagulation, and photodynamic therapies. These conventional treatments focus on reducing abnormal blood vessel formation in the retina, which, in a low-oxygen environment, can lead to harmful proliferation of endothelial cells. This results in dysfunctional, leaky blood vessels that cause retinal edema, hemorrhage, and vision loss.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!